Home › Funds › Richmond Brothers, Inc. › CNTB
Richmond Brothers, Inc. position in CNTB
CONNECT BIOPHARMA HLDGS LTD · Health Care
Richmond Brothers, Inc. reported holding 535,612 shares of CNTB (CONNECT BIOPHARMA HLDGS LTD) in its Q2 2026 13F filing — a position valued at US$1.3M, representing 0.66% of its reported portfolio and ranking #47 among its reported holdings. Richmond Brothers, Inc. has disclosed CNTB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Richmond Brothers, Inc.'s CNTB position evolved
Richmond Brothers, Inc. first disclosed a stake in CNTB in Q4 2025 at 173,485 shares (US$489K). The position peaked in Q2 2026 at 535,612 shares, worth US$1.3M. Across 3 filings, Richmond Brothers, Inc. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 535,612 shares valued at US$1.3M — an increase of 59,028 shares quarter over quarter.. Notable position changes include a 175% increase in Q1 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 173.49K | $489.23K | New |
| Q1 2026 | 476.58K | $1.25M | Add |
| Q2 2026 | 535.61K | $1.27M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNTB and 13F data
CNTB (CONNECT BIOPHARMA HLDGS LTD) is a Health Care company. 62 other funds we track also report a position in CNTB — the largest reported positions include Ikarian Capital, LLC (US$10.8M), BML Capital Management, LLC (US$1.4M), Knott David M Jr (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNTB
- Ikarian Capital, LLC 4.54M sh · $10.80M · Q2 2026
- BML Capital Management, LLC 573.29K sh · $1.36M · Q2 2026
- Knott David M Jr 444.86K sh · $1.06M · Q2 2026
- Stonepine Capital Management, LLC 364.25K sh · $866.92K · Q2 2026
More on Richmond Brothers, Inc.
FAQ
How long has Richmond Brothers, Inc. held CNTB?
Richmond Brothers, Inc. has disclosed CNTB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Richmond Brothers, Inc.'s current position in CNTB?
As of Q2 2026, Richmond Brothers, Inc. holds 535.61K shares of CNTB (CONNECT BIOPHARMA HLDGS LTD), valued at $1.27M, representing 0.66% of its reported portfolio and ranking #47.
Has Richmond Brothers, Inc. been buying or selling CNTB?
In the latest 13F filing (Q2 2026), Richmond Brothers, Inc. increased its position in CNTB. The position peaked in Q2 2026 at 535.61K shares.
Which other funds hold CNTB?
Other major institutional holders of CNTB include Ikarian Capital, LLC, BML Capital Management, LLC, Knott David M Jr, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.